Kayentis
- Website
- kayentis.com
- Total Funding
- $8.3M
- Last Round
- Growth EquityAug 2024
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Kayentis is a Drug Discovery company. It has raised $8.3M in total across 2 rounds, most recently a Growth Equity round in Aug 2024. Investors include LBO France and Bpifrance.
Funding History
Aug 2024
Sign up to see all 2 events
Funding: Growth Equity. Amounts, valuations, and investors where available.
Investors
Similar Companies
The nation's first company to integrate specialty pharmacies into hospitals and health systems, h...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/kayentis"><img src="https://indexed.vc/api/badge/company/kayentis" alt="Kayentis on Indexed.vc" width="260" height="76" /></a>

